NCIt definition : A humanized IgG1 monoclonal antibody directed against the cell surface glycoprotein
CD-38 with potential antineoplastic activity. Isatuximab specifically binds to CD38
on CD38-positive tumor cells. This may trigger antitumoral antibody-dependent cellular
cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC) and apoptosis eventually
leading to cell lysis in CD38-expressing tumor cells. CD38, a type II transmembrane
glycoprotein, is present on various immune cells and hematologic malignancies, and
its expression has been correlated with poor prognosis.;
UNII : R30772KCU0;
CAS number : 1461640-62-9; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1461640-62-9
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Drug name : Sarclisa;
Molecule name : SAR-650984; Hu 38SB19; SAR 650984;